Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.42SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XASYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CY.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.13.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.11.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.258.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.4.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ED.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CQ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.38.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.19.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
AY.29 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ML.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.38.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BT.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.55SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.6.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used